Needham & Company's Fifth Annual Biotechnology and Medical Technology Conference in New York on June 14-15; Medical Technology Companies Included for First Time; Record Number of Companies to Present.

NEW YORK -- Needham & Company, LLC will hold its Fifth Annual Biotechnology and Medical Technology Conference at the New York Palace Hotel on June 14 and 15. A record 124 biotechnology and medical technology companies are scheduled to present. For a full list of companies, please go to: www.needhamco.com.

"We are delighted to be hosting our Fifth Annual Conference," said Dr. Mark Monane, Managing Director, Equity Research, Biotechnology and Life Sciences. "As always, we have timed our conference the week following the American Society of Clinical Oncology (ASCO) Annual Meeting so that the information coming out of that event can be analyzed and discussed at the Needham Conference. This year, we are welcoming medical technology companies to the conference for the first time. Our clients have expressed a desire to include this important sector, and we are pleased to have some great medical technology companies presenting."

Some of the topics that attending companies will cover are:

Cancer:        Breakthroughs in leukemia
Obesity:       Using natural hormones to reduce the desire to eat
Pain:          A medical issue, not a normal part of growing old
Avian Flu:     How the industry is responding to a possible epidemic
Medical Tech:  Successful aging - advances in lasers
Heart Disease: Unclogging the arteries - new approaches

    In addition to company presentations, there will be several
special panel discussions on cancer, infectious diseases, CNS
metabolic issues, and cardiovascular breakthroughs during the first
day of the conference:

Wednesday, June 14:

10:00 am    CNS Metabolic Panel

10:00 am    Cancer Panel

3:00 pm     Infectious Diseases Panel

3:00 pm     Cardiovascular Panel

About Needham & Company, LLC

Needham & Company, LLC is a wholly owned subsidiary of The Needham Group, Inc. and a privately held, full-service investment bank with the mission of helping emerging growth companies achieve their potential. The firm is headquartered in New York City with offices in Boston, Menlo Park and San Francisco. In addition to investment banking, Needham's principal activities include institutional sales and trading, asset management and venture capital. To serve its institutional clients, Needham & Company, LLC produces comprehensive equity research on more than 375 companies in technology, health care, consumer and industrial growth. For more information, please see www.needhamco.com.